The Promise Of Genome Editing With Caribou Biosciences' Rachel Haurwitz, Ph.D.
Source: Applied Biosystems by Thermo Fisher Scientific, qPCR

On this episode of Cell & Gene: The Podcast, Rachel Haurwitz, Ph.D., CEO at Caribou Biosciences joins Host Erin Harris to discuss the evolution of genome editing, its present state, as well as its undeniable potential. Listen now to learn more about Caribou's chRDNA genome editing technology and how it differs from CRISPR-Cas9.
access the Podcast!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Advancing RNA? Subscribe today.
Subscribe to Advancing RNA
X
Subscribe to Advancing RNA
Applied Biosystems by Thermo Fisher Scientific, qPCR
This website uses cookies to ensure you get the best experience on our website. Learn more